Navigation Links
Hutchinson Center Receives $7.6 Million Federal Grant to Study How Genetic Variations Influence Risk of Common Diseases
Date:7/17/2008

SEATTLE, July 17 /PRNewswire/ -- Researchers at Fred Hutchinson Cancer Research Center have received a $7.6 million, four-year grant from the National Human Genome Research Institute to better understand the genetic and biological roots of common diseases. The Hutchinson Center is one of four U.S. research institutes to receive grants totaling about $31 million toward this effort.

The Hutchinson Center project, led by biostatistician and principal investigator Charles Kooperberg, Ph.D., and epidemiologist and co-principal investigator Ulrike "Riki" Peters, Ph.D., both of the Center's Public Health Sciences Division, will study how specific genetic variants influence the risk of diabetes, heart disease, cancer and other common conditions, from obesity to dementia.

Mining more than a decade of data from the Women's Health Initiative, an ethnically and socio-economically diverse study population involving nearly 162,000 postmenopausal women nationwide, Kooperberg and colleagues will look also at how previously identified genetic variants are related to biological and physical characteristics associated with disease risk, such as weight, cholesterol and blood-sugar levels, and bone density. The scientists also will examine how lifestyle factors, such as diet, medications and smoking, may interact with genetic factors to influence health outcomes. For example, if a person follows a low-fat diet high in fruits and vegetables, would that lessen or negate the disease risk associated with a specific genetic variant?

"Through previous genome-wide association studies we know there are common genetic variants in the population that are associated with a moderate increase in the risk of various diseases. Now we want to know how environmental exposures and lifestyle factors, such as diet or smoking, influence disease risk in people with these genetic variants," Peters said.

Another goal of the study is to examine the pathways by which these genetic variants influence disease. "We hope to learn more about the mechanisms by looking at the associations between these genetic variations and intermediate biomarkers of disease, such as cholesterol levels as a marker for heart disease and bone density as a marker for hip fractures," she said.

To this end, the researchers will aim to genotype blood samples from 58,000 WHI study participants to investigate up to 100 known disease-specific genetic variants.

"Information generated from this study will be critical to determine the health impact of any given genetic variant and to prioritize them for intervention studies aimed to reduce their associated risk," Kooperberg said. "These findings may also provide valuable insights into disease pathways and mechanisms, and identify targets for disease screening, prevention and treatment."

The Hutchinson Center's Public Health Sciences Division houses the Clinical Coordinating Center for the Women's Health Initiative, one of the most definitive, far-reaching studies of postmenopausal women's health ever undertaken in the United States. Enrollment began in 1993 and participants will be followed at least until 2010. The study examines the prevalence and risk factors for a number of diseases common in aging women, as well as the effects of various interventions, from low-fat diets and hormone therapy to calcium and vitamin D supplementation.

"We are extremely grateful for the study participants who have provided a wealth of biological data that will permit us to link genetic variants to relevant intermediate biomarkers that will potentially provide important clues to the biological basis of the disease," Kooperberg said.

Also collaborating on the project, in addition Kooperberg, Peters and colleagues from the WHI Clinical Coordinating Center, are investigators from the University of Arizona Cancer Center, Ohio State University and the University of Pittsburgh.

For more information about the NHGRI program and the other grantees, please visit http://www.genome.gov/27527085 .

At Fred Hutchinson Cancer Research Center, our interdisciplinary teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Our researchers, including three Nobel laureates, bring a relentless pursuit and passion for health, knowledge and hope to their work and to the world. For more information, please visit fhcrc.org.

CONTACT

Kristen Woodward

206-667-5095

kwoodwar@fhcrc.org


'/>"/>
SOURCE Fred Hutchinson Cancer Research Center
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Fred Hutchinson Cancer Research Center and NSB POSTECH, Inc. to Collaborate on Development of New Class of Proteomic Microarrays
2. University of Miami Miller School of Medicine Becomes a GeneGo Center of Excellence
3. N.C. Biotech Center Launches Larger Loans
4. NorthPoint Domain and Boston Medical Center Partner to Apply Advanced Patient Engagement Instruments to Pioneering Cardiac Robotic Surgery Program
5. Yale Keck Microarray Center Becomes a GeneGo Center of Excellence
6. CET Life Sciences Center Welcomes Belmont University School of Pharmacy as New Tenant
7. N.C. Biotechnology Center Launches Industrial Fellowship Program
8. Worldwide Center for Adult Stem Cell Education LLC Changes Name to The Repair Stem Cell Institute LLC
9. U.S. Commerce Secretary Gutierrez Cuts Ribbon on MaxWell Biocorporations New Pharmaceutical Development Center and Quality Control Laboratory in Ukraine
10. TCN e-Systems Offers Trial Sponsors Solutions for Creating In-House Center of Excellence in Patient Recruitment
11. Spine Surgeons at Pine Creek Medical Center Take the Lead in Utilizing Stem Cell Technologies in Surgical Procedures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... EDISON, N.J. , Feb. 4, 2016 ... company focused on the development and commercialization of targeted ... BIO CEO & Investor Conference 2016, to be held ... and Source Capital Group,s 2016 Disruptive Growth & Healthcare ... on February 10-11, 2016. James Sapirstein ...
(Date:2/4/2016)... , February 4, 2016 ... Laboratories (ABL), Inc. --> Strasbourg, France ... --> PharmaVentures is pleased to announce that it ... its biopharmaceutical manufacturing unit in Strasbourg, France ... --> --> Transgene (Euronext: ...
(Date:2/3/2016)... -- With the growing need for better therapeutics, and ... such as monoclonal antibodies, recombinant protein therapeutics and ... are in high demand. Conventionally expression systems were ... of these therapeutics. However, due to issues with ... approaches and novel expression systems are currently being ...
(Date:2/3/2016)... ... February 03, 2016 , ... ... a new office dedicated to the North American healthcare market. , Aerocom Healthcare, ... healthcare facilities. The company will provide new pneumatic tube systems or expand ...
Breaking Biology Technology:
(Date:1/20/2016)... Jan. 20, 2016  Synaptics Incorporated (NASDAQ: ... solutions, today announced sampling of S1423, its newest ... and small screen applications including smartwatches, fitness trackers, ... round and rectangular shapes, as well as thick ... with moisture on screen, while wearing gloves, and ...
(Date:1/13/2016)... New York , January 13, 2016 ... Market Research has published a new market report titled ... Growth, Trends, and Forecast, 2015 - 2023. According to the ... in 2014 and is anticipated to reach US$1,625.8 mn ... 2015 to 2023. In terms of volume, the biometric ...
(Date:1/11/2016)... , Jan. 11, 2016  higi, the leading ... 10,000 retail locations, web and mobile, today announced ... million from existing investors. --> ... devoted to further innovate higi,s health platform – ... web portal – including expanding services and programs ...
Breaking Biology News(10 mins):